Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Validated tools for alcohol and drug misuse, such as the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Abuse Screening Test (DAST), are readily available and can be administered ...

Recent research has unveiled a significant correlation between alcohol consumption patterns and sports betting behaviors, ...

This indicates that most consumers are drinking within the Health NZs low-risk drinking advice. For women this is drinking no more than two standard drinks a day, and three standard drinks a day for ...

There are many resources to support parents of children with developmental disabilities, and help them to understand their ...

BACKGROUND: Research indicates that patients undergoing bariatric surgery face a six to seven times higher risk of developing alcohol use disorder (AUD) compared with the population of obese ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

In addition to the association between decreased AUDIT-C score and decreased all-cause hospital risk, researchers found that this relationship was dose dependent, with more decreases in score ...

One tool used worldwide to identify AUD is the Alcohol Use Disorder Identification Tool (AUDIT), developed by WHO (Higgins-Biddle and Babor, 2018). While the classification of AUD has changed over the ...

and hazardous alcohol use was assessed using the 10-item Alcohol Use Disorder Identification Test (AUDIT). Data entry was done using EpiData Version 4.6, and analysis was carried out with SPSS Version ...